Prevention of de novo HBV infection by the presence of anti-HBs in transplanted patients receiving core antibody-positive livers

Table 1 Features of donors and liver recipients

Pt.	Age (yr)	Sex	Liver transplantindications	Donor HBV status		Recipient pre-LT HBVstatus		Liver HBV-DNA(mo after LT)	Latestanti-HBs levels	Follow-up(mo)
				anti-HBc	anti-HBs	anti-HBc	anti-HBs
1	58	M	HCV cirrhosis	+	-	+	V	13 + (RC)	ND	66
2	46	F	Cryptogenic cirrhosis	+	-	+	V (>10)	1 -	-	69
3	62	M	Alcoholic cirrhosis	+	+	+	+	ND	ND	70
4	66	M	HCV cirrhosis	+	+	+	+	0 -	ND	71
5	55	F	HCV cirrhosis	+	+	-	+ V (>10)	0 -	-	51
								12 -
								36 -
6	44	M	HCV cirrhosis	+	-	-	+ V (>100)	4 -	+	63
								12 -
7	63	M	HCV cirrhosis	+	+	-	+ V (>100)	1 -	ND	74
8	54	M	HCV cirrhosis	+	-	+	+	2 -	+	76
								28 -
9	41	M	HCV/alcoholic cirrhosis	+	+	+	- V (<10)	23 + (RC)	-	66
10	52	F	Alcoholic cirrhosis	+	+	-	+ V (>50)	ND	-	52
11	40	M	HCV/alcoholic cirrhosis	+	-	-	+ V (>50)	0 -	-	56
12	65	M	Alcoholic cirrhosis/HCC	+	+	-	+ V (>10)	0 -	-	61
13	50	F	Cryptogenic cirrhosis	+	+	-	+ V (>10)	ND	-	39
14	67	F	HCV cirrhosis/HCC	+	+	-	+ V (>10)	14 -	+	36
15	67	M	HCV cirrhosis	+	+	-	+ V (>10)	ND	ND	36
16	60	M	Alcoholic cirrhosis	+	+	-	+ V (>10)	1 -	ND	32
17	62	M	HCV/HCC	+	ND	+	-	6 -	-	31
18	67	M	Alcoholic cirrhosis	+		-	+ V (>10)	ND	ND	28
19	46	F	HCV cirrhosis	+	+	+	-	ND	ND	24
20	58	M	Alcoholic cirrhosis	+		+	+	ND	ND	18
21	49	M	HCV/alcoholic cirrhosis/HCC	+	+	-	+ V (>10)	5 -	ND	18
22	56	M	Alcoholic cirrhosis	+	+	+	+	ND	ND	17
23	57	M	Alcoholic cirrhosis	+	+	+	+	ND	+	16

HCV: hepatitis C virus; HCC: hepatocellular carcinoma; HBV: hepatitis B virus; V: HBV vaccine; RC: partially double-stranded HBV DNA genome; ND: not determined.